Company Intco Medical Technology Co., Ltd.
Equities
300677
CNE100003456
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 51.31 CNY | +1.89% |
|
-0.85% | +31.90% |
| 04-23 | Intco Medical Technology Q1 net profit down 97.2% y/y | RE |
| 04-23 | Intco Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Business description: Intco Medical Technology Co., Ltd.

Number of employees: 12,941
Sales by Activity: Intco Medical Technology Co., Ltd.
| Fiscal Period: December | 2021 (CNY) | 2022 (CNY) | 2023 (CNY) | 2024 (CNY) | 2025 (CNY) |
|---|---|---|---|---|---|
Personal Protection | 15.81B | 6.01B | 6.18B | 8.6B | 8.84B |
Other | 178M | 231M | 343M | 466M | 643M |
Rehabilitation Nursing Category | 255M | 378M | 396M | 458M | 448M |
Geographical breakdown of sales: Intco Medical Technology Co., Ltd.
| Fiscal Period: December | 2021 (CNY) | 2022 (CNY) | 2023 (CNY) | 2024 (CNY) | 2025 (CNY) |
|---|---|---|---|---|---|
Overseas | 13.76B | 5.48B | 6B | 8.06B | 8.15B |
China | 2.48B | 1.14B | 917M | 1.46B | 1.77B |
Executive Committee: Intco Medical Technology Co., Ltd.
| Manager | Title | Age | Since |
|---|---|---|---|
Qiong Chen
CEO | Chief Executive Officer | 44 | 16/04/2015 |
Jie Feng
DFI | Director of Finance/CFO | 41 | 15/10/2018 |
Hai Sheng Yu
PRN | Corporate Officer/Principal | 50 | 31/08/2009 |
Wen Jing Liu
IRC | Investor Relations Contact | - | - |
Bin Li
IRC | Investor Relations Contact | 43 | - |
Composition of the Board of Directors: Intco Medical Technology Co., Ltd.
| Director | Title | Age | Since |
|---|---|---|---|
Qiong Chen
BRD | Director/Board Member | 44 | 16/04/2015 |
Fang Yi Liu
CHM | Chairman | 56 | 16/04/2015 |
Jing Sun
BRD | Director/Board Member | 50 | 16/04/2015 |
Hai Sheng Yu
BRD | Director/Board Member | 50 | 15/10/2018 |
Ye Tang
CHM | Chairman | 43 | 13/03/2022 |
Yang Wang
BRD | Director/Board Member | 47 | 13/03/2022 |
Xiao Hui Wu
BRD | Director/Board Member | 55 | 17/04/2022 |
Jing Xiang
BRD | Director/Board Member | 50 | 13/03/2022 |
Juan Xu
BRD | Director/Board Member | 39 | 13/03/2022 |
Wenning Zhai
BRD | Director/Board Member | 39 | 13/03/2022 |
Company details: Intco Medical Technology Co., Ltd.
Intco Medical Technology Co., Ltd.
18 Qingtian Road
255414, Zibo
+86 53 3609 8666
http://www.intcomedical.com
Medical Supplies
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.89% | -0.85% | +121.93% | +115.05% | 4.88B | ||
| +1.25% | +0.95% | -37.26% | -55.71% | 14.18B | ||
| +2.12% | +0.52% | +365.31% | +174.32% | 3.64B | ||
| -1.62% | -5.57% | -39.10% | -28.51% | 2.6B | ||
| -0.29% | -1.71% | -42.28% | -71.94% | 1.99B | ||
| -0.62% | -5.29% | -4.17% | -32.92% | 1.63B | ||
| -0.16% | -5.19% | -34.69% | -50.58% | 1.11B | ||
| -3.77% | -11.92% | +29.83% | +0.18% | 1.02B | ||
| 0.00% | -1.62% | +25.52% | +51.67% | 1.05B | ||
| -2.27% | -0.86% | +32.56% | -8.79% | 944M | ||
| Average | -0.35% | -1.66% | +41.76% | +9.28% | 3.31B | |
| Weighted average by Cap. | +0.69% | -0.99% | +37.90% | +3.78% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Annual profits - Rate of surprise
- Stock Market
- Equities
- 300677 Stock
- Company Intco Medical Technology Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















